Scott Kathleen D.
SEC insider (Form 3/4/5 filer). CIK 0001794284. Director at Dermata Therapeutics, Inc. (DRMA) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in SAN DIEGO, CA.
Companies Scott Kathleen D. has filed insider reports for
- Dermata Therapeutics, Inc. (DRMA): Director
- ARS Pharmaceuticals, Inc. (SPRY): Officer, Chief Financial Officer
- NKGen Biotech, Inc. (NKGN): Director
Scott Kathleen D.
CIK: 0001794284
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 16, 2026DRMA
Dermata Therapeutics, Inc.
SaleDirect11 shares at avg. $1.19$13.091 - Jan 2, 2026DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
2.5K shares- - Jan 2, 2026SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
240K shares- - Aug 21, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleDirect12.5K shares at avg. $15.00$188K - Aug 21, 2025SPRY
ARS Pharmaceuticals, Inc.
ExerciseDirect12.5K shares at avg. $1.50$19K - May 20, 2025SPRY
ARS Pharmaceuticals, Inc.
ExerciseDirect50K shares at avg. $1.50$75K - May 20, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleDirect50K shares at avg. $14.10$705K - Jan 13, 2025DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5K shares- - Jan 2, 2025SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
176.7K shares- - Dec 6, 2024NKGN
NKGen Biotech, Inc.
AwardDirectStock Option (right to buy)
300K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  DRMA Dermata Therapeutics, Inc. | Sale | 11 | $1.19 | $13 | Direct |
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (Right to Buy) | 2,500 | - | - | Direct |
| Jan 2, 2026 |  SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 240,000 | - | - | Direct |
| Aug 21, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 12,500 | $15.00 | $187,500 | Direct |
| Aug 21, 2025 | SPRY ARS Pharmaceuticals, Inc. | Exercise | 12,500 | $1.50 | $18,750 | Direct |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Exercise | 50,000 | $1.50 | $75,000 | Direct |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 50,000 | $14.10 | $705,165 | Direct |
| Jan 13, 2025 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,000 | - | - | Direct |
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 176,700 | - | - | Direct |
| Dec 6, 2024 |  NKGN NKGen Biotech, Inc. | Award Stock Option (right to buy) | 300,000 | - | - | Direct |
1-10 of 13 transactions